PF4-heparin antibodies during ECMO: incidence, course, and outcomes
Crossref DOI link: https://doi.org/10.1007/s00134-016-4262-2
Published Online: 2016-02-22
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Laverdure, Florent
Louvain-Quintard, Virginie
Kortchinsky, Talna
Rezaiguïa-Delclaux, Saïda
Imbert, Audrey
Stéphan, François
Text and Data Mining valid from 2016-02-22